🇺🇸 BAT1806 in United States

6 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Alanine Aminotransferase Increased — 1 report (16.67%)
  2. Aspartate Aminotransferase Increased — 1 report (16.67%)
  3. Hypertriglyceridaemia — 1 report (16.67%)
  4. Hyperuricaemia — 1 report (16.67%)
  5. Neutrophil Count Decreased — 1 report (16.67%)
  6. White Blood Cell Count Decreased — 1 report (16.67%)

Source database →

Other Oncology approved in United States

Frequently asked questions

Is BAT1806 approved in United States?

BAT1806 does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for BAT1806 in United States?

Bio-Thera Solutions is the originator. The local marketing authorisation holder may differ — check the official source linked above.